Lixte Biotechnology Holdings, Inc. (LIXT) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -1.83M | -1.09M | -926.75K | -487.49K | -568.48K | -598.67K | -957.6K | -819.04K | -789.23K | -902.12K | -944.39K | -1.18M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -222.15% | -81.72% | 3.22% | 40.48% | 27.97% | 33.64% | -1.4% | 30.32% | 37.92% | 25.35% | 19.55% | 1.58% |
| Net Income | -1.92M | -2.54M | -1.98M | -775.67K | -709.55K | -617.69K | -986.03K | -1.01M | -971.32K | -1.03M | -1.02M | -1.67M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 370.87K | 821.32K | 268K | 99.74K | 77.98K | 106.83K | 130.69K | 102.93K | 0 | 112.11K | 280.06K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 194.2K | 783.2K | 182.89K | 0 | 0 | 0 | 0 | 0 | 0 | 104.06K | 0 | 0 |
| Working Capital Changes | -101.88K | 301.92K | 49.44K | 20.19K | 41.33K | -58.96K | -78.39K | 61.19K | 79.17K | 26.07K | -37.73K | 212.91K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -45.4K | 0 | 59.22K | -20.33K | 56.77K | 0 | -65.47K | -115.28K | 89.93K | -65.38K | -145.36K | 142.9K |
| Cash from Investing | -24.86K | -535.1K | -2.64M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures | -24.86K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -95.1K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 0 | 3.84M | 5.56M | -10K | 914.23K | 0 | 0 | 0 | 0 | 0 | 3.14M | 0 |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 3.84M | 5.56M | -10K | 914.23K | 0 | 0 | 0 | 0 | 0 | 3.14M | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41 | 0 |
| Net Change in Cash | -1.86M | 2.22M | 2M | -497.49K | 345.75K | -598.67K | -957.6K | -819.04K | -789.23K | -902.12K | 2.19M | -1.18M |
| Free Cash Flow | -1.86M | -1.09M | -926.75K | -487.48K | -568.48K | -598.67K | -957.6K | -819.04K | -789.23K | -902.12K | -944.39K | -1.18M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -226.52% | -81.72% | 3.22% | 40.48% | 27.97% | 33.64% | -1.4% | 30.32% | 37.92% | 25.35% | 19.55% | 1.58% |
| FCF per Share | -0.17 | -0.02 | -0.15 | -0.18 | -0.23 | -0.27 | -0.43 | -0.36 | -0.35 | -0.40 | -0.46 | -0.71 |
| FCF Conversion (FCF/Net Income) | 0.95x | 0.43x | 0.46x | 0.63x | 0.80x | 0.97x | 0.97x | 0.81x | 0.81x | 0.87x | 0.93x | 0.70x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 4.43K | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |